FENTANYL CITRATE

FENTANYL CITRATE was reported 17838 times

FENTANYL CITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 72 0.2376
1 CHEST WALL RIGIDITY 9 0.1406
2 ANTERIOR SPINAL ARTERY SYNDROME 10 0.1190
3 CHANTER SYNDROME 11 0.1100
4 BURKHOLDERIA TEST POSITIVE 13 0.1048
5 DEPENDENCE 3935 0.0717
6 SUBSTANCE DEPENDENCE 47 0.0698
7 NARCOTIC INTOXICATION 17 0.0659
8 AUTOIMMUNE LUNG DISEASE 7 0.0593
9 LEARNING DISORDER 139 0.0576
10 AIRWAY PEAK PRESSURE INCREASED 8 0.0526
11 NEUROMUSCULAR BLOCK PROLONGED 19 0.0515
12 SPEECH DISORDER DEVELOPMENTAL 138 0.0481
13 FEMALE GENITAL TRACT FISTULA 77 0.0451
14 AMNESTIC DISORDER 19 0.0390
15 ELECTROCARDIOGRAM PR SHORTENED 7 0.0333
16 HEPATIC ISCHAEMIA 10 0.0322
17 PROCEDURAL HYPOTENSION 27 0.0317
18 DELAYED RECOVERY FROM ANAESTHESIA 30 0.0316
19 HYPERTHERMIA MALIGNANT 47 0.0316
20 ANION GAP 20 0.0315
21 CARCINOID CRISIS 7 0.0310
22 RADICULOPATHY 78 0.0296
23 OPIATES POSITIVE 13 0.0271
24 POSTMORTEM BLOOD DRUG LEVEL INCREASED 10 0.0268
25 RESPIRATORY ARREST 737 0.0267
26 AIRWAY COMPLICATION OF ANAESTHESIA 7 0.0266
27 PROCTITIS 74 0.0264
28 XERODERMA 7 0.0262
29 GROWTH DISORDER 7 0.0259
30 SUBSTANCE USE 39 0.0250
31 ATTENTION DEFICIT HYPERACTIVITY DISORDER 92 0.0218
32 DRUG WITHDRAWAL SYNDROME NEONATAL 321 0.0217
33 TOXICOLOGIC TEST ABNORMAL 13 0.0215
34 ILL-DEFINED DISORDER 1288 0.0212
35 DRUG ABUSE 1737 0.0208
36 TOXIC LEUKOENCEPHALOPATHY 15 0.0207
37 BLOOD PRESSURE MEASUREMENT 13 0.0202
38 HYPERMOBILITY SYNDROME 10 0.0201
39 CHRONIC SINUSITIS 74 0.0197
40 RESPIRATORY DEPRESSION 232 0.0189
41 ANAESTHETIC COMPLICATION 49 0.0182
42 BULIMIA NERVOSA 8 0.0182
43 SEDATION COMPLICATION 46 0.0180
44 PRODUCT COUNTERFEIT 31 0.0180
45 HEARING DISABILITY 7 0.0179
46 ANALGESIC DRUG LEVEL INCREASED 27 0.0168
47 DEVELOPMENTAL DELAY 146 0.0162
48 APNOEIC ATTACK 9 0.0160
49 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 261 0.0152
50 LABILE BLOOD PRESSURE 18 0.0152
51 ANTEROGRADE AMNESIA 9 0.0150
52 FOETAL EXPOSURE DURING DELIVERY 10 0.0147
53 RENAL ISCHAEMIA 8 0.0146
54 ACUTE LUNG INJURY 17 0.0143
55 RESPIRATORY RATE DECREASED 45 0.0143
56 MATERNAL EXPOSURE DURING DELIVERY 14 0.0141
57 BRADYPNOEA 38 0.0141
58 MIOSIS 108 0.0134
59 WRONG TECHNIQUE IN DRUG USAGE PROCESS 488 0.0134
60 BRADYCARDIA FOETAL 11 0.0132
61 TONGUE PARALYSIS 9 0.0126
62 RETINOPATHY OF PREMATURITY 7 0.0126
63 TRYPTASE INCREASED 9 0.0126
64 ACCIDENTAL OVERDOSE 457 0.0125
65 ACCIDENTAL POISONING 17 0.0124
66 APPLICATION SITE EROSION 15 0.0116
67 ARACHNOIDITIS 8 0.0116
68 DRUG DIVERSION 71 0.0115
69 SUBSTANCE ABUSE 93 0.0114
70 ENDOTRACHEAL INTUBATION 32 0.0114
71 OVERDOSE 2456 0.0114
72 TERMINAL INSOMNIA 20 0.0113
73 RESPIRATORY ACIDOSIS 44 0.0112
74 CARDIAC ARREST 918 0.0111
75 APNOEA 84 0.0108
76 PAROTID GLAND ENLARGEMENT 7 0.0107
77 MYOCARDIAL INJURY 12 0.0107
78 UPPER AIRWAY OBSTRUCTION 9 0.0101
79 INADEQUATE ANALGESIA 86 0.0101
80 ELECTROMECHANICAL DISSOCIATION 8 0.0100
81 POLYHYDRAMNIOS 10 0.0098
82 SEPTIC EMBOLUS 8 0.0096
83 VEIN COLLAPSE 7 0.0091
84 BRAIN DEATH 28 0.0091
85 RESUSCITATION 15 0.0090
86 DISTURBANCE IN SOCIAL BEHAVIOUR 21 0.0089
87 DRUG ADMINISTERED AT INAPPROPRIATE SITE 93 0.0088
88 SEROTONIN SYNDROME 169 0.0088
89 GASTROINTESTINAL BACTERIAL INFECTION 10 0.0087
90 ANASTOMOTIC LEAK 6 0.0086
91 SLOW RESPONSE TO STIMULI 11 0.0085
92 PRODUCT TAMPERING 15 0.0083
93 PCO2 DECREASED 8 0.0083
94 SEIZURE LIKE PHENOMENA 14 0.0082
95 TOXICITY TO VARIOUS AGENTS 1385 0.0082
96 UNRESPONSIVE TO STIMULI 208 0.0081
97 WITHDRAWAL SYNDROME 337 0.0080
98 DEAFNESS NEUROSENSORY 26 0.0079
99 DRUG USE DISORDER 66 0.0078
100 CAUDA EQUINA SYNDROME 6 0.0078
101 DRUG TOLERANCE 39 0.0077
102 DRUG TOLERANCE INCREASED 6 0.0077
103 SENSITIVITY TO WEATHER CHANGE 39 0.0074
104 PARAPARESIS 13 0.0073
105 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 16 0.0073
106 CONVERSION DISORDER 14 0.0072
107 HEPATORENAL SYNDROME 12 0.0071
108 HYPERCAPNIA 21 0.0070
109 DRUG EFFECT INCREASED 22 0.0070
110 DRUG PRESCRIBING ERROR 133 0.0069
111 VAGINAL DISCHARGE 69 0.0068
112 INTERVERTEBRAL DISC COMPRESSION 7 0.0067
113 PULSELESS ELECTRICAL ACTIVITY 28 0.0067
114 POTENTIATING DRUG INTERACTION 22 0.0065
115 POISONING 82 0.0065
116 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 17 0.0065
117 BREAKTHROUGH PAIN 15 0.0065
118 MATERNAL EXPOSURE TIMING UNSPECIFIED 24 0.0064
119 AUTISM SPECTRUM DISORDER 35 0.0064
120 HYPOVENTILATION 20 0.0061
121 PO2 DECREASED 7 0.0061
122 HYPERAESTHESIA 50 0.0061
123 EXPOSURE VIA BREAST MILK 24 0.0060
124 LARYNGOSPASM 16 0.0059
125 DRUG TOXICITY 81 0.0059
126 POSTPARTUM HAEMORRHAGE 8 0.0059
127 COMA SCALE ABNORMAL 17 0.0059
128 ORAL CANDIDIASIS 77 0.0058
129 CARDIO-RESPIRATORY ARREST 242 0.0058
130 MACULAR DEGENERATION 69 0.0058
131 LARGE INTESTINE INFECTION 7 0.0057
132 PULSE ABSENT 27 0.0057
133 STRESS CARDIOMYOPATHY 33 0.0057
134 ENDOCARDITIS 29 0.0056
135 WEIGHT BEARING DIFFICULTY 15 0.0056
136 LEUKOENCEPHALOPATHY 20 0.0054
137 SUBSTANCE USE DISORDER 17 0.0053
138 AREFLEXIA 14 0.0052
139 POST-TRAUMATIC STRESS DISORDER 35 0.0052
140 VENTRICULAR ARRHYTHMIA 19 0.0052
141 PNEUMONIA STAPHYLOCOCCAL 10 0.0051
142 COMPARTMENT SYNDROME 13 0.0050
143 DISINHIBITION 8 0.0050
144 HYPOVOLAEMIA 29 0.0050
145 PARAESTHESIA ORAL 71 0.0049
146 APPLICATION SITE SCAR 6 0.0048
147 PREMATURE BABY 142 0.0047
148 METABOLIC ENCEPHALOPATHY 14 0.0047
149 ALCOHOL INTERACTION 9 0.0046
150 VENTRICULAR FIBRILLATION 51 0.0046
151 SPINAL CORD INJURY 8 0.0046
152 MYOGLOBIN BLOOD INCREASED 7 0.0046
153 PRODUCT ADHESION ISSUE 163 0.0046
154 BRAIN OEDEMA 57 0.0045
155 BRAIN INJURY 45 0.0045
156 ARTERIOSPASM CORONARY 18 0.0045
157 SINUS ARREST 7 0.0045
158 FUNGAEMIA 7 0.0044
159 PROCEDURAL COMPLICATION 34 0.0044
160 DEPRESSED LEVEL OF CONSCIOUSNESS 175 0.0044
161 MUSCLE RIGIDITY 52 0.0043
162 HYPERREFLEXIA 15 0.0043
163 PERFORMANCE STATUS DECREASED 20 0.0043
164 ATRIOVENTRICULAR BLOCK SECOND DEGREE 13 0.0043
165 VASOPLEGIA SYNDROME 7 0.0043
166 STAPHYLOCOCCUS TEST POSITIVE 9 0.0043
167 DELIRIUM 148 0.0043
168 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 14 0.0042
169 FOETAL EXPOSURE DURING PREGNANCY 341 0.0042
170 NYSTAGMUS 22 0.0041
171 ALCOHOL POISONING 11 0.0041
172 NORMAL NEWBORN 22 0.0040
173 HEART INJURY 10 0.0040
174 CLONUS 11 0.0040
175 IMPRISONMENT 7 0.0040
176 LUNG CONSOLIDATION 11 0.0039
177 ACCIDENTAL DRUG INTAKE BY CHILD 6 0.0039
178 SELF-MEDICATION 16 0.0039
179 INTENTIONAL DRUG MISUSE 81 0.0039
180 PNEUMOMEDIASTINUM 7 0.0039
181 IMPAIRED DRIVING ABILITY 44 0.0039
182 MYOCARDIAL ISCHAEMIA 44 0.0039
183 IMMUNE-MEDIATED LUNG DISEASE 7 0.0038
184 APPLICATION SITE REACTION 27 0.0038
185 DILATATION VENTRICULAR 8 0.0038
186 DYSENTERY 7 0.0038
187 HYPOPNOEA 13 0.0037
188 COMPRESSION FRACTURE 20 0.0037
189 PULMONARY OEDEMA 167 0.0037
190 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 19 0.0037
191 LIVE BIRTH 31 0.0037
192 HYDROCEPHALUS 20 0.0037
193 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
194 COMPLETED SUICIDE 303 0.0036
195 LEARNING DISABILITY 19 0.0036
196 HYPERAEMIA 7 0.0035
197 BRADYCARDIA 187 0.0035
198 KOUNIS SYNDROME 8 0.0035
199 MYOCLONUS 42 0.0035
200 ANAPHYLACTIC SHOCK 90 0.0035
201 HYPOXIA 121 0.0034
202 CARDIOMEGALY 42 0.0034
203 SPINAL STENOSIS 14 0.0034
204 PULMONARY ALVEOLAR HAEMORRHAGE 19 0.0034
205 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 23 0.0034
206 COLITIS 127 0.0033
207 CIRCULATORY COLLAPSE 57 0.0033
208 DENTAL CARIES 37 0.0033
209 FREQUENT BOWEL MOVEMENTS 90 0.0033
210 VENTRICULAR TACHYCARDIA 55 0.0033
211 SINUS TACHYCARDIA 47 0.0033
212 DISABILITY 64 0.0032
213 POST PROCEDURAL COMPLICATION 62 0.0032
214 OSTEOMYELITIS 58 0.0032
215 INCORRECT ROUTE OF DRUG ADMINISTRATION 114 0.0032
216 OXYGEN SATURATION DECREASED 179 0.0032
217 CLOSTRIDIUM TEST POSITIVE 7 0.0032
218 HAEMODYNAMIC INSTABILITY 24 0.0031
219 DRUG LEVEL INCREASED 52 0.0031
220 ILEUS PARALYTIC 14 0.0031
221 TOOTH LOSS 65 0.0031
222 INCREASED BRONCHIAL SECRETION 8 0.0031
223 PULMONARY CONGESTION 41 0.0031
224 CLEFT PALATE 6 0.0031
225 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 19 0.0031
226 NECK INJURY 9 0.0031
227 DIPLEGIA 6 0.0030
228 EUPHORIC MOOD 31 0.0030
229 BRONCHOSPASM 43 0.0030
230 HYPERTHERMIA 23 0.0030
231 METABOLIC ACIDOSIS 96 0.0030
232 ATELECTASIS 29 0.0030
233 ALCOHOL ABUSE 8 0.0030
234 SKIN ABRASION 14 0.0030
235 SUPRAVENTRICULAR EXTRASYSTOLES 10 0.0030
236 PROCEDURAL PAIN 82 0.0030
237 TORSADE DE POINTES 23 0.0029
238 APPLICATION SITE VESICLES 19 0.0029
239 ANAPHYLACTOID REACTION 12 0.0029
240 ACIDOSIS 22 0.0029
241 ARTERIOSCLEROSIS 27 0.0029
242 INCORRECT DRUG ADMINISTRATION RATE 12 0.0028
243 STUPOR 9 0.0028
244 ACUTE RESPIRATORY DISTRESS SYNDROME 49 0.0028
245 KLEBSIELLA INFECTION 14 0.0028
246 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
247 CANCER PAIN 7 0.0027
248 LUMBAR SPINAL STENOSIS 8 0.0027
249 PARANOIA 47 0.0027
250 INTESTINAL ISCHAEMIA 15 0.0027
251 EXTRASYSTOLES 19 0.0027
252 RHABDOMYOLYSIS 112 0.0027
253 ANAPHYLACTIC REACTION 148 0.0027
254 BRAIN HERNIATION 8 0.0027
255 PNEUMOTHORAX 42 0.0026
256 ABNORMAL LOSS OF WEIGHT 18 0.0026
257 BLOOD PRESSURE SYSTOLIC DECREASED 12 0.0026
258 COMA 125 0.0026
259 HYPERNATRAEMIA 13 0.0026
260 RECTAL CANCER 8 0.0026
261 FIBROSIS 8 0.0026
262 LARYNGEAL OEDEMA 16 0.0026
263 ABDOMINAL RIGIDITY 7 0.0026
264 COAGULOPATHY 43 0.0026
265 LARGE INTESTINAL ULCER 7 0.0026
266 PREMATURE DELIVERY 41 0.0026
267 HYPOALBUMINAEMIA 20 0.0026
268 DRUG WITHDRAWAL SYNDROME 224 0.0026
269 CYANOSIS 40 0.0025
270 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
271 TACHYPNOEA 34 0.0025
272 ILEUS 31 0.0025
273 MENTAL STATUS CHANGES 69 0.0025
274 ORGAN FAILURE 10 0.0025
275 PARADOXICAL DRUG REACTION 9 0.0024
276 PARAPLEGIA 7 0.0024
277 NEAR DEATH EXPERIENCE 8 0.0024
278 DYSPHAGIA 230 0.0024
279 LIVER FUNCTION TEST INCREASED 52 0.0024
280 PEPTIC ULCER 8 0.0024
281 DEATH 2065 0.0024
282 DRUG DEPENDENCE 385 0.0024
283 DRUG INTERACTION 376 0.0024
284 RENAL FAILURE CHRONIC 18 0.0023
285 PROTHROMBIN TIME PROLONGED 14 0.0023
286 DYSCHEZIA 7 0.0023
287 GRAND MAL CONVULSION 21 0.0023
288 DISSEMINATED INTRAVASCULAR COAGULATION 32 0.0023
289 HYPERTONIA 13 0.0023
290 CEREBRAL ATROPHY 9 0.0023
291 MULTI-ORGAN FAILURE 39 0.0023
292 PRODUCT CONTAMINATION 8 0.0022
293 HYPERVENTILATION 13 0.0022
294 PNEUMONIA ASPIRATION 56 0.0022
295 ABDOMINAL MASS 6 0.0022
296 AGITATION 164 0.0022
297 MULTIPLE DRUG OVERDOSE 11 0.0022
298 LUMBAR VERTEBRAL FRACTURE 10 0.0022
299 APPLICATION SITE RASH 30 0.0022
300 VENTRICULAR HYPOKINESIA 7 0.0022
301 GASTROINTESTINAL PERFORATION 9 0.0022
302 CAESAREAN SECTION 25 0.0021
303 LISTLESS 7 0.0021
304 CHOLECYSTITIS ACUTE 12 0.0021
305 GENERALISED TONIC-CLONIC SEIZURE 35 0.0021
306 PARALYSIS 30 0.0021
307 METASTASES TO SPINE 7 0.0021
308 ALTERED STATE OF CONSCIOUSNESS 45 0.0021
309 HYPOTENSION 416 0.0021
310 SINUS BRADYCARDIA 20 0.0021
311 SPINAL CORD COMPRESSION 8 0.0021
312 PNEUMONIA FUNGAL 8 0.0020
313 ASPIRATION 22 0.0020
314 FOREIGN BODY 8 0.0020
315 PRODUCT QUALITY ISSUE 271 0.0020
316 NECROTISING FASCIITIS 7 0.0020
317 PRODUCT SOLUBILITY ABNORMAL 10 0.0020
318 RECTAL HAEMORRHAGE 85 0.0020
319 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
320 COLITIS ULCERATIVE 88 0.0020
321 ROAD TRAFFIC ACCIDENT 82 0.0020
322 PETIT MAL EPILEPSY 10 0.0020
323 TACHYCARDIA 173 0.0019
324 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
325 TUMOUR LYSIS SYNDROME 17 0.0019
326 PELVIC PAIN 35 0.0019
327 VENTRICULAR EXTRASYSTOLES 20 0.0019
328 RESPIRATORY FAILURE 140 0.0019
329 PULMONARY HAEMORRHAGE 15 0.0019
330 DISTURBANCE IN ATTENTION 102 0.0019
331 NEUROTOXICITY 33 0.0019
332 DISORIENTATION 74 0.0019
333 APPLICATION SITE PRURITUS 42 0.0018
334 DERMATITIS CONTACT 21 0.0018
335 SEDATION 48 0.0018
336 IMMOBILE 8 0.0018
337 FAECALOMA 10 0.0018
338 GASTROINTESTINAL DISORDER 163 0.0018
339 GASTROOESOPHAGEAL REFLUX DISEASE 146 0.0018
340 MUSCULOSKELETAL PAIN 95 0.0018
341 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
342 HYPOTHERMIA 18 0.0018
343 NEUROLEPTIC MALIGNANT SYNDROME 21 0.0018
344 ENCEPHALOPATHY 43 0.0017
345 CACHEXIA 9 0.0017
346 FOETAL DEATH 9 0.0017
347 DRUG EXPOSURE DURING PREGNANCY 59 0.0017
348 PERIORBITAL OEDEMA 9 0.0017
349 URINE OUTPUT DECREASED 15 0.0017
350 LEUKOCYTOSIS 31 0.0017
351 GOITRE 7 0.0017
352 FLANK PAIN 16 0.0017
353 ARTHRITIS BACTERIAL 7 0.0017
354 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12 0.0017
355 HYPOVOLAEMIC SHOCK 8 0.0017
356 BONE LESION 6 0.0017
357 CARDIAC FAILURE ACUTE 11 0.0016
358 HYPERBILIRUBINAEMIA 17 0.0016
359 BLOOD PRESSURE DECREASED 109 0.0016
360 SEPTIC SHOCK 71 0.0016
361 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
362 STAPHYLOCOCCAL SEPSIS 8 0.0016
363 HEPATOTOXICITY 36 0.0016
364 GAIT INABILITY 54 0.0016
365 ACUTE RESPIRATORY FAILURE 31 0.0016
366 PRODUCT PRESCRIBING ISSUE 35 0.0016
367 BACTERAEMIA 19 0.0016
368 RESPIRATORY DISTRESS 44 0.0016
369 CORONARY ARTERY STENOSIS 8 0.0016
370 GENERALISED ERYTHEMA 9 0.0016
371 HEPATITIS C 19 0.0016
372 COMMUNICATION DISORDER 6 0.0016
373 BURSITIS 19 0.0016
374 HAEMATOCHEZIA 86 0.0016
375 PULMONARY TOXICITY 11 0.0016
376 CEREBRAL ISCHAEMIA 8 0.0016
377 OROPHARYNGEAL DISCOMFORT 14 0.0015
378 METABOLIC DISORDER 9 0.0015
379 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
380 HEPATIC FAILURE 46 0.0015
381 BEDRIDDEN 20 0.0015
382 MALNUTRITION 17 0.0015
383 DRUG SCREEN POSITIVE 12 0.0015
384 BLOOD ALBUMIN DECREASED 12 0.0015
385 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
386 MULTIPLE MYELOMA 7 0.0015
387 CANDIDIASIS 6 0.0015
388 MATERNAL EXPOSURE DURING PREGNANCY 133 0.0015
389 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
390 HYPOACUSIS 64 0.0015
391 RENAL FAILURE ACUTE 63 0.0015
392 WRONG PRODUCT ADMINISTERED 10 0.0015
393 POISONING DELIBERATE 14 0.0015
394 SOMNOLENCE 296 0.0015
395 DRUG ABUSER 9 0.0015
396 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
397 BLOOD TESTOSTERONE DECREASED 10 0.0015
398 APHAGIA 7 0.0015
399 LIVER FUNCTION TEST ABNORMAL 42 0.0014
400 HYPERTENSIVE CRISIS 16 0.0014
401 DEPRESSION 327 0.0014
402 FORMICATION 10 0.0014
403 INTRACRANIAL PRESSURE INCREASED 8 0.0014
404 HYPOKALAEMIA 66 0.0014
405 AMNESIA 93 0.0014
406 ACUTE PULMONARY OEDEMA 8 0.0014
407 HEPATIC FUNCTION ABNORMAL 53 0.0014
408 CARDIOGENIC SHOCK 20 0.0014
409 SHOCK 32 0.0014
410 INCOHERENT 9 0.0014
411 TOXIC ENCEPHALOPATHY 7 0.0014
412 SCIATICA 22 0.0014
413 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
414 POST PROCEDURAL HAEMORRHAGE 16 0.0014
415 MOTOR DYSFUNCTION 14 0.0014
416 ASTHMA 155 0.0014
417 APPLICATION SITE IRRITATION 17 0.0014
418 COLD SWEAT 24 0.0014
419 TRISMUS 7 0.0014
420 TREATMENT NONCOMPLIANCE 74 0.0014
421 SEPSIS 149 0.0013
422 CATATONIA 7 0.0013
423 ORAL HERPES 26 0.0013
424 KIDNEY INFECTION 26 0.0013
425 BLOOD UREA INCREASED 22 0.0013
426 DISEASE COMPLICATION 6 0.0013
427 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
428 SLEEP APNOEA SYNDROME 25 0.0013
429 BODY HEIGHT DECREASED 14 0.0013
430 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
431 BREAST CANCER METASTATIC 14 0.0013
432 ANAL ABSCESS 7 0.0013
433 APPLICATION SITE ERYTHEMA 34 0.0013
434 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
435 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
436 LETHARGY 74 0.0013
437 CONSTIPATION 280 0.0013
438 PYELONEPHRITIS 11 0.0013
439 INFUSION RELATED REACTION 84 0.0013
440 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 90 0.0013
441 NEUTROPENIC SEPSIS 9 0.0013
442 TRICUSPID VALVE INCOMPETENCE 10 0.0013
443 RESTLESSNESS 46 0.0013
444 CARDIAC DISORDER 117 0.0012
445 DYSARTHRIA 47 0.0012
446 AFFECT LABILITY 12 0.0012
447 DRUG EFFECT DECREASED 67 0.0012
448 ASPARTATE AMINOTRANSFERASE INCREASED 66 0.0012
449 MEDICATION ERROR 69 0.0012
450 DRUG ADMINISTRATION ERROR 38 0.0012
451 PERIORBITAL SWELLING 7 0.0012
452 SUICIDE ATTEMPT 75 0.0012
453 ABNORMAL BEHAVIOUR 49 0.0012
454 NEURALGIA 30 0.0012
455 DECUBITUS ULCER 10 0.0012
456 RENAL TUBULAR NECROSIS 12 0.0012
457 ANAL INCONTINENCE 11 0.0012
458 METASTASES TO BONE 20 0.0012
459 DIABETIC NEUROPATHY 6 0.0012
460 THERAPEUTIC PRODUCT EFFECT DECREASED 54 0.0012
461 PSYCHOMOTOR HYPERACTIVITY 20 0.0012
462 EXOSTOSIS 11 0.0012
463 HYPOTONIA 12 0.0012
464 SECRETION DISCHARGE 15 0.0012
465 HALLUCINATION 90 0.0012
466 EXPOSURE DURING PREGNANCY 74 0.0012
467 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
468 EATING DISORDER 25 0.0012
469 ACCIDENT 14 0.0012
470 URINARY RETENTION 39 0.0012
471 HYPOCALCAEMIA 22 0.0012
472 RESPIRATION ABNORMAL 8 0.0012
473 LOSS OF CONSCIOUSNESS 148 0.0012
474 GROIN PAIN 10 0.0011
475 CONVULSION 65 0.0011
476 JOINT DISLOCATION 12 0.0011
477 SCOLIOSIS 7 0.0011
478 BLOOD PRESSURE SYSTOLIC INCREASED 22 0.0011
479 RESPIRATORY RATE INCREASED 10 0.0011
480 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 80 0.0011
481 OSTEOPENIA 17 0.0011
482 ELECTROCARDIOGRAM QT PROLONGED 40 0.0011
483 POST PROCEDURAL INFECTION 9 0.0011
484 RESPIRATORY DISORDER 33 0.0011
485 MENTAL DISORDER 48 0.0011
486 OVARIAN CYST 11 0.0011
487 FEBRILE NEUTROPENIA 73 0.0011
488 RESTLESS LEGS SYNDROME 20 0.0011
489 ACUTE HEPATIC FAILURE 15 0.0011
490 SPINAL COMPRESSION FRACTURE 9 0.0011
491 UROSEPSIS 10 0.0011
492 CONFUSIONAL STATE 173 0.0011
493 INJECTION SITE WARMTH 22 0.0011
494 CARDIOVASCULAR DISORDER 27 0.0011
495 CHROMATURIA 24 0.0011
496 MITRAL VALVE INCOMPETENCE 12 0.0011
497 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
498 SMALL INTESTINAL OBSTRUCTION 13 0.0011
499 NECK PAIN 59 0.0011
500 HYPERCALCAEMIA 13 0.0011
501 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
502 HYPERHIDROSIS 135 0.0010
503 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
504 MATERNAL DRUGS AFFECTING FOETUS 8 0.0010
505 ALANINE AMINOTRANSFERASE INCREASED 64 0.0010
506 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 50 0.0010
507 AGGRESSION 52 0.0010
508 BLOOD BILIRUBIN INCREASED 28 0.0010
509 HAEMOLYSIS 8 0.0010
510 ELECTROLYTE IMBALANCE 12 0.0010
511 BODY TEMPERATURE INCREASED 21 0.0010
512 INTENTIONAL PRODUCT MISUSE 90 0.0010
513 DYSPEPSIA 101 0.0010
514 SPINAL OSTEOARTHRITIS 9 0.0010
515 RENAL IMPAIRMENT 86 0.0010
516 HEPATOMEGALY 10 0.0010
517 RENAL FAILURE 135 0.0010
518 MYDRIASIS 13 0.0010
519 HAEMATOCRIT DECREASED 20 0.0010
520 CHOLECYSTITIS 12 0.0010
521 HYPERTRANSAMINASAEMIA 7 0.0010
522 PERICARDIAL EFFUSION 23 0.0010
523 SENSORY LOSS 8 0.0010
524 VISUAL IMPAIRMENT 123 0.0010
525 ANXIETY 282 0.0010
526 NERVE INJURY 11 0.0010
527 BONE DISORDER 18 0.0010
528 ANKYLOSING SPONDYLITIS 13 0.0010
529 HAEMATEMESIS 25 0.0010
530 RETINAL HAEMORRHAGE 7 0.0010
531 SHOCK HAEMORRHAGIC 8 0.0010
532 DRUG DISPENSING ERROR 15 0.0010
533 METASTASIS 7 0.0010
534 LIVER INJURY 24 0.0010
535 NERVE COMPRESSION 9 0.0010
536 PHARYNGEAL OEDEMA 15 0.0010
537 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0010
538 ANAEMIA 185 0.0010
539 PLEURAL EFFUSION 59 0.0010
540 CHOLANGITIS 6 0.0010
541 DELUSION 15 0.0010
542 PANCREATITIS 51 0.0010
543 DEFORMITY 9 0.0010
544 HAEMODIALYSIS 8 0.0010
545 ABDOMINAL PAIN LOWER 24 0.0009
546 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
547 CARDIOMYOPATHY 14 0.0009
548 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
549 ULCER 15 0.0009
550 HYPONATRAEMIA 53 0.0009
551 SEXUAL DYSFUNCTION 11 0.0009
552 PAIN 574 0.0009
553 FEELING HOT 57 0.0009
554 ANURIA 8 0.0009
555 HYPERTENSION 196 0.0009
556 INJURY 65 0.0009
557 BLOOD POTASSIUM INCREASED 15 0.0009
558 DRUG SPECIFIC ANTIBODY PRESENT 6 0.0009
559 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
560 HEPATOCELLULAR INJURY 13 0.0009
561 HYPERKALAEMIA 32 0.0009
562 DYSKINESIA 37 0.0009
563 SEIZURE 105 0.0009
564 HEART RATE INCREASED 90 0.0009
565 APPLICATION SITE PAIN 20 0.0009
566 C-REACTIVE PROTEIN INCREASED 33 0.0009
567 LUNG INFILTRATION 8 0.0009
568 ATRIOVENTRICULAR BLOCK 7 0.0009
569 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
570 PELVIC FRACTURE 7 0.0009
571 QUALITY OF LIFE DECREASED 12 0.0009
572 GASTROINTESTINAL INFLAMMATION 7 0.0009
573 EMPHYSEMA 9 0.0009
574 EMOTIONAL DISTRESS 108 0.0009
575 BACK PAIN 207 0.0009
576 ABDOMINAL PAIN 207 0.0009
577 FACE OEDEMA 15 0.0009
578 IMPAIRED WORK ABILITY 19 0.0009
579 VOMITING 417 0.0009
580 CYST 11 0.0009
581 TOOTH ABSCESS 9 0.0009
582 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
583 STAPHYLOCOCCAL INFECTION 29 0.0009
584 PNEUMONIA BACTERIAL 8 0.0009
585 PERITONITIS 18 0.0009
586 PERSONALITY CHANGE 8 0.0009
587 TRANSFUSION 9 0.0009
588 MASS 12 0.0009
589 ERYTHEMA MULTIFORME 8 0.0009
590 ACUTE KIDNEY INJURY 131 0.0009
591 HEART RATE DECREASED 30 0.0009
592 HALLUCINATION, VISUAL 18 0.0009
593 ESCHERICHIA INFECTION 7 0.0009
594 HYPERGLYCAEMIA 31 0.0008
595 HIATUS HERNIA 11 0.0008
596 HEAD DISCOMFORT 15 0.0008
597 MOOD SWINGS 27 0.0008
598 DRUG ERUPTION 15 0.0008
599 PNEUMONITIS 23 0.0008
600 DIVERTICULUM 6 0.0008
601 SUBDURAL HAEMATOMA 12 0.0008
602 NEOPLASM PROGRESSION 29 0.0008
603 PYREXIA 288 0.0008
604 SOPOR 11 0.0008
605 GENERAL PHYSICAL HEALTH DETERIORATION 96 0.0008
606 DERMATITIS BULLOUS 6 0.0008
607 TOOTHACHE 15 0.0008
608 ANGER 28 0.0008
609 BLOOD CREATININE INCREASED 54 0.0008
610 HYPOKINESIA 12 0.0008
611 MENTAL IMPAIRMENT 20 0.0008
612 AUTOIMMUNE DISORDER 8 0.0008
613 PRODUCT CONTAINER ISSUE 7 0.0008
614 CEREBRAL DISORDER 6 0.0008
615 MUSCLE STRAIN 7 0.0008
616 NEOPLASM MALIGNANT 54 0.0008
617 OSTEONECROSIS OF JAW 20 0.0008
618 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
619 GENERALISED OEDEMA 10 0.0008
620 COLON CANCER 12 0.0008
621 MUCOSAL INFLAMMATION 21 0.0008
622 OSTEOARTHRITIS 34 0.0008
623 STATUS EPILEPTICUS 9 0.0008
624 HYPOMAGNESAEMIA 11 0.0008
625 COORDINATION ABNORMAL 11 0.0008
626 MUSCULOSKELETAL STIFFNESS 69 0.0008
627 BONE MARROW FAILURE 16 0.0008
628 ACCIDENTAL EXPOSURE TO PRODUCT 81 0.0008
629 SUBARACHNOID HAEMORRHAGE 8 0.0008
630 CEREBRAL HAEMORRHAGE 28 0.0008
631 FIBROMYALGIA 19 0.0008
632 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
633 METASTASES TO LUNG 9 0.0008
634 PLATELET COUNT DECREASED 83 0.0008
635 TENDONITIS 12 0.0008
636 NAUSEA 607 0.0008
637 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 42 0.0008
638 TOOTH DISORDER 17 0.0008
639 INTERSTITIAL LUNG DISEASE 37 0.0008
640 DYSURIA 28 0.0008
641 NEUTROPHIL COUNT DECREASED 31 0.0008
642 SCRATCH 8 0.0008
643 IRON DEFICIENCY ANAEMIA 7 0.0008
644 DRUG INTOLERANCE 73 0.0008
645 OBESITY 12 0.0008
646 WEIGHT DECREASED 210 0.0008
647 ATRIAL FLUTTER 6 0.0008
648 CHILLS 88 0.0007
649 SENSORY DISTURBANCE 12 0.0007
650 HEPATIC CIRRHOSIS 14 0.0007
651 LIVER DISORDER 33 0.0007
652 JAUNDICE 20 0.0007
653 CRYING 27 0.0007
654 URINARY INCONTINENCE 22 0.0007
655 DEHYDRATION 99 0.0007
656 PHARYNGITIS STREPTOCOCCAL 8 0.0007
657 BACK DISORDER 12 0.0007
658 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
659 BACK INJURY 8 0.0007
660 LYMPHOCYTE COUNT DECREASED 13 0.0007
661 ASPHYXIA 6 0.0007
662 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
663 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
664 HYPOAESTHESIA ORAL 11 0.0007
665 ACUTE CORONARY SYNDROME 6 0.0007
666 SYNOVITIS 13 0.0007
667 PULMONARY HYPERTENSION 15 0.0007
668 ORAL DISCOMFORT 10 0.0007
669 OEDEMA 39 0.0007
670 DEVICE RELATED INFECTION 11 0.0007
671 INTESTINAL PERFORATION 8 0.0007
672 JOINT SWELLING 86 0.0007
673 BLOOD CALCIUM DECREASED 8 0.0007
674 INCORRECT DRUG ADMINISTRATION DURATION 20 0.0007
675 THROMBOCYTOPENIA 79 0.0007
676 HYPOPHAGIA 18 0.0007
677 INJECTION SITE MASS 26 0.0007
678 THINKING ABNORMAL 13 0.0007
679 HYPERSOMNIA 20 0.0007
680 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
681 POOR QUALITY SLEEP 15 0.0007
682 FLUID OVERLOAD 10 0.0007
683 SWELLING 64 0.0007
684 SPLENOMEGALY 8 0.0007
685 METASTASES TO LIVER 12 0.0007
686 ASCITES 20 0.0007
687 MALIGNANT NEOPLASM PROGRESSION 69 0.0007
688 RENAL INJURY 20 0.0007
689 PETECHIAE 7 0.0007
690 FEAR 18 0.0007
691 BLOOD PRESSURE FLUCTUATION 16 0.0007
692 INTESTINAL OBSTRUCTION 25 0.0007
693 ECONOMIC PROBLEM 10 0.0007
694 DISEASE PROGRESSION 78 0.0007
695 PANIC ATTACK 24 0.0007
696 RETCHING 14 0.0007
697 CEREBRAL INFARCTION 16 0.0007
698 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 34 0.0007
699 PRURITUS GENERALISED 14 0.0006
700 FAECES DISCOLOURED 14 0.0006
701 HAEMOPTYSIS 18 0.0006
702 PANCYTOPENIA 36 0.0006
703 THERAPEUTIC RESPONSE DECREASED 39 0.0006
704 INFECTION 93 0.0006
705 MUSCULAR WEAKNESS 73 0.0006
706 HAEMOGLOBIN DECREASED 65 0.0006
707 RIB FRACTURE 13 0.0006
708 IRRITABILITY 38 0.0006
709 BLOOD POTASSIUM DECREASED 19 0.0006
710 MOOD ALTERED 17 0.0006
711 PANCREATIC CARCINOMA 18 0.0006
712 FISTULA 7 0.0006
713 MYELODYSPLASTIC SYNDROME 9 0.0006
714 DYSPNOEA 352 0.0006
715 GALLBLADDER DISORDER 11 0.0006
716 DEEP VEIN THROMBOSIS 40 0.0006
717 HAEMATURIA 21 0.0006
718 ARRHYTHMIA 29 0.0006
719 PNEUMONIA 198 0.0006
720 CHOLELITHIASIS 20 0.0006
721 INTENTIONAL OVERDOSE 39 0.0006
722 ABASIA 15 0.0006
723 EXTRAPYRAMIDAL DISORDER 15 0.0006
724 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
725 ERYTHEMA 124 0.0006
726 CYTOKINE RELEASE SYNDROME 12 0.0006
727 CARDIAC FAILURE 48 0.0006
728 UNEVALUABLE EVENT 45 0.0006
729 MOVEMENT DISORDER 19 0.0006
730 MALAISE 259 0.0006
731 HEMIPARESIS 10 0.0006
732 IMPAIRED GASTRIC EMPTYING 8 0.0006
733 GAIT DISTURBANCE 112 0.0006
734 TREMOR 97 0.0006
735 PRODUCT PREPARATION ERROR 12 0.0006
736 SKIN LESION 16 0.0006
737 LYMPHOMA 9 0.0006
738 DRY EYE 29 0.0006
739 LUNG INFECTION 9 0.0006
740 GASTRIC ULCER 11 0.0006
741 ACUTE MYOCARDIAL INFARCTION 17 0.0006
742 CELLULITIS 29 0.0006
743 GASTROINTESTINAL HAEMORRHAGE 48 0.0006
744 NO THERAPEUTIC RESPONSE 7 0.0006
745 DECREASED APPETITE 133 0.0006
746 SPEECH DISORDER 30 0.0006
747 DEMENTIA 16 0.0006
748 ANHEDONIA 15 0.0006
749 MOUTH ULCERATION 12 0.0006
750 SPINAL OPERATION 7 0.0006
751 SLEEP DISORDER 40 0.0006
752 HAEMORRHOIDS 11 0.0006
753 RHEUMATOID ARTHRITIS 64 0.0006
754 TOOTH EXTRACTION 7 0.0006
755 CORONARY ARTERY DISEASE 17 0.0006
756 LACTIC ACIDOSIS 18 0.0006
757 ATRIAL FIBRILLATION 54 0.0006
758 HYPERTHYROIDISM 8 0.0006
759 MUSCLE ATROPHY 7 0.0006
760 CHEST PAIN 102 0.0006
761 SPINAL FRACTURE 11 0.0005
762 SUICIDAL IDEATION 50 0.0005
763 MELAENA 12 0.0005
764 WHITE BLOOD CELL COUNT DECREASED 59 0.0005
765 ADVERSE EVENT 50 0.0005
766 DRUG INEFFECTIVE 715 0.0005
767 VISION BLURRED 74 0.0005
768 PULMONARY MASS 8 0.0005
769 RENAL DISORDER 25 0.0005
770 HAEMORRHAGE 56 0.0005
771 COGNITIVE DISORDER 25 0.0005
772 HAEMORRHAGE INTRACRANIAL 8 0.0005
773 APHASIA 16 0.0005
774 BURNING SENSATION 37 0.0005
775 NIGHT SWEATS 17 0.0005
776 INSOMNIA 140 0.0005
777 NEPHROLITHIASIS 24 0.0005
778 OFF LABEL USE 458 0.0005
779 MUSCULOSKELETAL DISCOMFORT 9 0.0005
780 LEUKOPENIA 26 0.0005
781 THROAT TIGHTNESS 14 0.0005
782 PRESCRIBED OVERDOSE 10 0.0005
783 NERVOUSNESS 27 0.0005
784 LIMB INJURY 14 0.0005
785 PERIPHERAL COLDNESS 7 0.0005
786 SYNCOPE 51 0.0005
787 COVID-19 PNEUMONIA 6 0.0005
788 PSYCHOTIC DISORDER 15 0.0005
789 ATAXIA 6 0.0005
790 PULMONARY EMBOLISM 48 0.0005
791 INFLAMMATION 26 0.0005
792 SKIN ULCER 13 0.0005
793 ABSCESS 8 0.0005
794 DEAFNESS 13 0.0005
795 LYMPHOPENIA 7 0.0005
796 DIALYSIS 7 0.0005
797 PANCREATITIS ACUTE 11 0.0005
798 OCULAR HYPERAEMIA 23 0.0005
799 NERVOUS SYSTEM DISORDER 15 0.0005
800 APATHY 7 0.0005
801 GASTROENTERITIS 7 0.0005
802 URTICARIA 80 0.0005
803 MUSCLE TWITCHING 11 0.0005
804 DERMATITIS ALLERGIC 6 0.0005
805 ASTHENIA 179 0.0005
806 FRACTURE 9 0.0005
807 HYPERSENSITIVITY 86 0.0005
808 HAEMATOMA 12 0.0005
809 RESPIRATORY TRACT INFECTION 12 0.0005
810 SURGERY 27 0.0005
811 PRODUCT USE IN UNAPPROVED INDICATION 114 0.0005
812 DEVICE FAILURE 7 0.0005
813 OEDEMA PERIPHERAL 56 0.0005
814 ORTHOSTATIC HYPOTENSION 8 0.0005
815 MYOCARDIAL INFARCTION 80 0.0005
816 EPILEPSY 14 0.0005
817 CONDITION AGGRAVATED 139 0.0005
818 LOCALISED INFECTION 11 0.0005
819 HYPOAESTHESIA 68 0.0005
820 THYROID DISORDER 7 0.0005
821 PRESYNCOPE 11 0.0005
822 ANGIOEDEMA 20 0.0005
823 MIGRAINE 43 0.0004
824 LUNG DISORDER 22 0.0004
825 FALL 149 0.0004
826 DIABETES MELLITUS 34 0.0004
827 BLINDNESS 18 0.0004
828 PALLOR 12 0.0004
829 WHEEZING 26 0.0004
830 BLOOD PRESSURE INCREASED 67 0.0004
831 LUNG NEOPLASM MALIGNANT 18 0.0004
832 CARDIAC FAILURE CONGESTIVE 35 0.0004
833 FEELING ABNORMAL 104 0.0004
834 RHINORRHOEA 28 0.0004
835 DIVERTICULITIS 12 0.0004
836 BRONCHITIS 32 0.0004
837 ABDOMINAL PAIN UPPER 89 0.0004
838 HEADACHE 271 0.0004
839 AGRANULOCYTOSIS 8 0.0004
840 DISCOMFORT 26 0.0004
841 MULTIPLE FRACTURES 7 0.0004
842 DYSPNOEA EXERTIONAL 16 0.0004
843 LYMPHADENOPATHY 15 0.0004
844 DIPLOPIA 11 0.0004
845 DIZZINESS 210 0.0004
846 LIP SWELLING 14 0.0004
847 MUSCLE SPASMS 77 0.0004
848 ANGINA PECTORIS 12 0.0004
849 CHOLESTASIS 8 0.0004
850 BALANCE DISORDER 36 0.0004
851 DYSTONIA 8 0.0004
852 HYPOGLYCAEMIA 20 0.0004
853 INTENTIONAL PRODUCT USE ISSUE 36 0.0004
854 HEAD INJURY 13 0.0004
855 CYSTITIS 13 0.0004
856 LABORATORY TEST ABNORMAL 12 0.0004
857 PRODUCT USE ISSUE 76 0.0004
858 OROPHARYNGEAL PAIN 37 0.0004
859 PRODUCT PHYSICAL ISSUE 8 0.0004
860 FEELING COLD 11 0.0004
861 WOUND 11 0.0004
862 MEMORY IMPAIRMENT 54 0.0004
863 GOUT 7 0.0004
864 EMOTIONAL DISORDER 12 0.0004
865 NEUROPATHY PERIPHERAL 37 0.0004
866 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
867 STOMATITIS 23 0.0004
868 VERTIGO 23 0.0004
869 CONJUNCTIVITIS 7 0.0004
870 PRODUCTIVE COUGH 18 0.0004
871 HEPATIC STEATOSIS 7 0.0004
872 NIGHTMARE 13 0.0004
873 ABDOMINAL DISTENSION 39 0.0004
874 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
875 DIARRHOEA 240 0.0004
876 BLOOD SODIUM DECREASED 7 0.0004
877 ARTHRALGIA 154 0.0004
878 FLATULENCE 21 0.0004
879 URINARY TRACT INFECTION 63 0.0004
880 DRUG DOSE OMISSION 61 0.0004
881 CHRONIC KIDNEY DISEASE 28 0.0004
882 ERUCTATION 7 0.0004
883 CYTOMEGALOVIRUS INFECTION 6 0.0004
884 TRANSAMINASES INCREASED 8 0.0004
885 CHOKING 7 0.0004
886 DRY MOUTH 29 0.0004
887 HEART RATE IRREGULAR 8 0.0004
888 SINUS DISORDER 7 0.0004
889 SWELLING FACE 23 0.0004
890 NEUTROPENIA 48 0.0004
891 CATARACT 21 0.0004
892 HEPATITIS 9 0.0004
893 PRURITUS 135 0.0004
894 ERECTILE DYSFUNCTION 9 0.0004
895 RED BLOOD CELL COUNT DECREASED 10 0.0003
896 INJECTION SITE REACTION 24 0.0003
897 PAIN IN EXTREMITY 102 0.0003
898 PSORIATIC ARTHROPATHY 14 0.0003
899 CONTUSION 33 0.0003
900 DYSSTASIA 10 0.0003
901 CEREBROVASCULAR ACCIDENT 58 0.0003
902 GASTRITIS 9 0.0003
903 OSTEOPOROSIS 14 0.0003
904 PRODUCT PRESCRIBING ERROR 8 0.0003
905 RASH ERYTHEMATOUS 16 0.0003
906 HOT FLUSH 25 0.0003
907 ARTHRITIS 26 0.0003
908 BONE PAIN 19 0.0003
909 BLOOD CHOLESTEROL INCREASED 15 0.0003
910 BACTERIAL INFECTION 6 0.0003
911 EPISTAXIS 24 0.0003
912 BLISTER 18 0.0003
913 DRUG-INDUCED LIVER INJURY 10 0.0003
914 PAIN IN JAW 9 0.0003
915 ABDOMINAL DISCOMFORT 53 0.0003
916 GASTRIC CANCER 8 0.0003
917 FLUSHING 32 0.0003
918 FATIGUE 244 0.0003
919 HERPES ZOSTER 18 0.0003
920 HYPOTHYROIDISM 10 0.0003
921 ORAL PAIN 7 0.0003
922 HEPATIC ENZYME INCREASED 21 0.0003
923 OSTEONECROSIS 10 0.0003
924 TYPE 2 DIABETES MELLITUS 10 0.0003
925 CHEST DISCOMFORT 30 0.0003
926 SINUSITIS 30 0.0003
927 MOBILITY DECREASED 21 0.0003
928 ADVERSE DRUG REACTION 26 0.0003
929 BONE DENSITY DECREASED 9 0.0003
930 INFLUENZA LIKE ILLNESS 23 0.0003
931 SKIN DISORDER 9 0.0003
932 COUGH 75 0.0003
933 MYALGIA 45 0.0003
934 EAR INFECTION 7 0.0003
935 GASTRIC DISORDER 9 0.0003
936 RASH 113 0.0003
937 PALPITATIONS 30 0.0003
938 PARAESTHESIA 40 0.0003
939 ARTHROPATHY 14 0.0003
940 THROMBOSIS 20 0.0002
941 DRUG EFFECT INCOMPLETE 9 0.0002
942 THERAPY NON-RESPONDER 11 0.0002
943 IMPAIRED HEALING 8 0.0002
944 PRODUCT SUBSTITUTION ISSUE 14 0.0002
945 TINNITUS 11 0.0002
946 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
947 FLUID RETENTION 12 0.0002
948 HOSPITALISATION 36 0.0002
949 PLASMA CELL MYELOMA 9 0.0002
950 TREATMENT FAILURE 19 0.0002
951 RASH MACULAR 8 0.0002
952 WEIGHT INCREASED 51 0.0002
953 SWOLLEN TONGUE 7 0.0002
954 THROAT IRRITATION 10 0.0002
955 NASAL CONGESTION 13 0.0002
956 INJECTION SITE ERYTHEMA 27 0.0002
957 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
958 VISUAL ACUITY REDUCED 7 0.0002
959 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
960 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
961 SKIN DISCOLOURATION 9 0.0002
962 POLLAKIURIA 8 0.0002
963 DEPRESSED MOOD 10 0.0002
964 DEVICE LEAKAGE 8 0.0002
965 SKIN IRRITATION 8 0.0002
966 NASOPHARYNGITIS 32 0.0002
967 INCORRECT DOSE ADMINISTERED 39 0.0002
968 PROSTATE CANCER 13 0.0002
969 DYSGEUSIA 12 0.0002
970 THERAPY CESSATION 8 0.0002
971 ILLNESS 16 0.0002
972 DYSPHONIA 9 0.0002
973 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
974 MULTIPLE SCLEROSIS 7 0.0001
975 BREAST CANCER 13 0.0001
976 INFLUENZA 15 0.0001
977 DEVICE MALFUNCTION 9 0.0001
978 BLOOD GLUCOSE INCREASED 24 0.0001
979 INJECTION SITE PRURITUS 8 0.0001
980 SKIN BURNING SENSATION 8 0.0001
981 PERIPHERAL SWELLING 16 0.0001
982 BLADDER CANCER 6 0.0001
983 ALOPECIA 20 0.0001
984 COVID-19 17 0.0001
985 ACNE 7 0.0001
986 INJECTION SITE HAEMORRHAGE 7 0.0001
987 PSORIASIS 11 0.0001
988 SKIN EXFOLIATION 7 0.0001
989 NO ADVERSE EVENT 15 0.0001
990 PRODUCT DOSE OMISSION ISSUE 23 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
992 DRY SKIN 9 0.0001
993 INJECTION SITE PAIN 10 0.0000